英文别名: |
Olopatadine Hydrochloride;OLOPATADINE HCL;OLOPATDINEHYDROCHLORIDE;OLOPATADINE HYDROCHLORIDE AND THE INTERMEDIATES;(Z)-11-[3-(Dimethylamino)propylidene]-6,11-dihydrodibenz[b,e]oxepin-2-acetic acid hydrochloride;OLAPATADINE HCL;Olopatadine (hydrochloride);Olopatadine Hydrochl;ALO4943A;KW4679;(11Z)-11-[3-(Dimethylamino)propylidene]-6,11-dihydrodibenz[b,e]oxepin-2-acetic acid hydrochloride;AL-4943A;KW-4679;Opatanol;Patanol;Pataday;Allelock;Patanase;Pazeo;KW 4679;2XG66W44KF;DSSTox_RID_81657;DSSTox_CID_26486;DSSTox_GSID_46486;Patadine;Olopine;Olopax;Olopatadine hydrochloride;CVS Eye Allergy Itch ReliefTwice Daily;ALO-4943A;ALO4943A;KW4679;AKOS015895232;Eye Allergy Itch and Redness ReliefTwice Daily Relief;OLOPATADINE HYDROCHLORIDE (USP MONOGRAPH);OLOPATADINE HYDROCHLORIDE [VANDF];RYALTRIS COMPONENT OLOPATADINE HYDROCHLORIDE;Olopatadine Hydrochloride Ophthalmic SolutionTwice Daily;Olopatadine hydrochloride [USAN:USP];Olopatadine Hydrochloride Ophthalmic;C72607;AKOS025149118;HVRLZEKDTUEKQH-NOILCQHBSA-N;s2494;Olopatadine hydrochloride- Bio-X;2-{2-[3-(dimethylamino)propylidene]-9-oxatricyclo[9.4.0.0,3,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-5-yl}acetic acid hydrochloride;Olopatadine hydrochloride (JP17/USP);BCP9001022;SR-01000763388;PATADAY ONCE DAILY RELIEF;OLOPATADINE HCl;MFCD00875716;Eye Allergy Itch ReliefOnce Daily Relief;Olopatadine Hydrochloride Ophthalmic Solution;Olopatadine hydrochloride [USAN];ALO 4943A;UNII-2XG66W44KF;OLOPATADINE HYDROCHLORIDE (USP-RS);O0361;CVS Eye Allergy Itch ReliefOnce Daily;Olopatadine hydrochloride (Opatanol);SR-01000763388-4;2-[(2Z)-2-[3-(dimethylamino)propylidene]-9-oxatricyclo[9.4.0.0,3,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-5-yl]acetic acid hydrochloride;O-PPDS;Patanol (TN);OLOPATADINE HYDROCHLORIDE [EMA EPAR];EN300-19652056;Eye Allergy Itch Relief;SCHEMBL23213;Q27255766;(Z)-11-[3-(Dimethylamino)propylidene]-6,11-dihydro-dibenz[b,e]oxepin-2-acetic acid hydrochloride;Olopatadine Hydrochloride Ophthalmic SolutionOnce Daily Relief;Tox21_112242_1;DTXCID8026486;Hydrochloride, Olopatadine;Olopatadine Hydrochlorde;Dibenz[b,e]oxepin-2-acetic acid, 11-[3-(dimethylamino)propylidene]-6,11-dihydro-, hydrochloride (1:1), (11Z)-;Dibenz(b,e)oxepin-2-acetic acid, 11-(3-(dimethylamino)propylidene)-6,11-dihydro-, hydrochloride, (Z)-;OLOPATADINE HYDROCHLORIDE COMPONENT OF RYALTRIS;A807652;D01192;(Z)-2-(11-(3-(dimethylamino)propylidene)-6,11-dihydrodibenzo[b,e]oxepin-2-yl)acetic acid hydrochloride;CHEMBL1719;Opatanol (TN);Z2568665949;NCGC00263532-01;AL4943A;KS-1228;BO164171;Olopatadine Hydrochloride USP, 0.1%;(11-((1Z)-3-(Dimethylamino)propylidene)-6,11-dihydrodibenzo(b,e)oxepin-2-yl)acetic acid monohydrochloride;DE 114;OLOPATADINE HYDROCHLORIDE [WHO-DD];Olopatadine hydrochloride, >=98% (HPLC);NCGC00164623-01;Tox21_112242;OLOPATADINE HYDROCHLORIDE [USP MONOGRAPH];Olopatadine hydrochloride, United States Pharmacopeia (U... |